NCT03805386View on ClinicalTrials.gov

Patient-Directed Postoperative Opioid Prescribing for Gynecologic Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

April 15, 2020

Study Completion Date

April 15, 2020

Conditions
GynecologySurgeryOpioid Use
Interventions
DRUG

Physician directed opioid prescribing

Oxycodone 5mg 1-2 tablets every 4 hours as needed for pain. 30 tablets will be provided.

DRUG

Patient directed opioid prescribing

Oxycodone 5mg amount ranging from 0 tablets to as much as 30 tablets as described in the standard of care.

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03805386 - Patient-Directed Postoperative Opioid Prescribing for Gynecologic Surgery | Biotech Hunter | Biotech Hunter